Clinical Trials Logo

Clinical Trial Summary

This study has investigated the quality of life of patients with vestibular schwannoma using this specific scale prospectively, whether treated surgically or monitored.


Clinical Trial Description

The PANQOL scale (Penn Acoustic Neuroma Quality-of-Life) is a specific questionnaire containing 26 items Interviewing 7 areas: hearing, balance, facial expression, anxiety, vitality, pain, and 'general health. The score is encrypted from 0 to 100, and the highest score is a reflection of the best possible quality of life. This score has been translated from French into English and validated according to the reverse translation rules by usual Oddon et al.

Three questions for this score were added, evaluating quality of life parameters that seem particularly interesting: the first regarding the difficulties in driving, the second questioning the recovery of a "normal" life, and the third assessing difficulties in working life.

The questionnaires are sent to the patient in the form of a custom web link generated on the online survey platform SurveyMonkey, and integrated into the body of an email sent from the mailbox of the investigator Hospital. There is any identifying or indirectly identifying data on the questionnaire online, guaranteeing protection of the rights of the individual. Only the principal investigator and co-investigator retain the link between the coded identity of persons undergoing research used to associate personal health data and their name (s) and name (s) (correspondence table retained securely to the paper). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04004377
Study type Observational
Source University Hospital, Bordeaux
Contact Severin BELLEUDY
Phone +335 56 79 55 42
Email severin.belleudy@chu-bordeaux.fr
Status Recruiting
Phase
Start date December 5, 2018
Completion date December 5, 2020

See also
  Status Clinical Trial Phase
Active, not recruiting NCT01199978 - Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma Phase 2
Completed NCT00863122 - Concentration and Activity of Lapatinib in Vestibular Schwannomas Early Phase 1
Recruiting NCT03079999 - Study of Aspirin in Patients With Vestibular Schwannoma Phase 2
Completed NCT03210285 - WES of NF2-associated in Comparison to Sporadic Vestibular Schwannomas - Correlation With Clinical Data
Active, not recruiting NCT04241679 - Auditory Nerve Test System During Vestibular Schwannoma Resection N/A
Recruiting NCT03393689 - RGD PET/MRI in Sporadic Vestibular Schwannoma Phase 2
Not yet recruiting NCT06112509 - Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgery N/A
Withdrawn NCT03057678 - Evaluating the Pre-Positioning Frame for Robotic Acoustic Neuroma Removal Surgery N/A
Terminated NCT02282917 - Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma Early Phase 1
Withdrawn NCT03261726 - Maintaining Cochlear Patency After VIIIth Nerve Surgery N/A